Literature DB >> 32251238

OUTCOMES OF COMBINED PHACOEMULSIFICATION AND PARS PLANA VITRECTOMY FOR RHEGMATOGENOUS RETINAL DETACHMENT: A Comparative Study.

Alexia Tan1, Mathilde Bertrand-Boiché, Karine Angioi-Duprez, Jean-Paul Berrod, Jean-Baptiste Conart.   

Abstract

PURPOSE: To evaluate and to compare the anatomical and functional results of phacovitrectomy and pars plana vitrectomy (PPV) alone for phakic rhegmatogenous retinal detachment.
METHODS: Retrospective, comparative case series of 266 phakic eyes that underwent either combined phacovitrectomy or PPV alone for primary retinal detachment. The primary anatomical success rate, the final best-corrected visual acuity, and the refractive outcomes were analyzed.
RESULTS: One hundred and twenty-seven eyes were included in the combined group and 139 in the PPV group. The primary anatomical success rate was 84.3% in the combined group and 89.2% in the PPV group (P = 0.311). One hundred and nine (78.4%) eyes of the PPV group required cataract removal for visual rehabilitation during the follow-up period. There was no significant difference between the two groups in terms of the mean final best-corrected visual acuity (P = 0.185) and mean visual changes (P = 0.470). Overall, combined cataract extraction resulted in a significant myopic shift compared with delayed cataract surgery (P = 0.047).
CONCLUSION: Combined phacoemulsification and PPV is a safe and effective procedure to treat retinal detachment. The anatomical and functional results were comparable with those obtained with PPV and delayed cataract surgery. However, the refractive outcomes were less favorable and shifted toward myopia, especially in macula-off cases.

Entities:  

Year:  2021        PMID: 32251238     DOI: 10.1097/IAE.0000000000002803

Source DB:  PubMed          Journal:  Retina        ISSN: 0275-004X            Impact factor:   4.256


  7 in total

Review 1.  Pars plana vitrectomy combined with phacoemulsification versus pars plana vitrectomy only for treatment of phakic rhegmatogenous retinal detachment: a systematic review and meta-analysis.

Authors:  Ahmad Mirshahi; Elias Khalilipour; Hooshang Faghihi; Hamid Riazi-Esfahani; Romina Mirshahi; Hadi Z Mehrjardi; Ehsan Najibzadeh; Abdulrahim Amini; Amin Nabavi
Journal:  Int Ophthalmol       Date:  2022-08-19       Impact factor: 2.029

2.  Change in axial length after vitrectomy with silicone oil tamponade for rhegmatogenous retinal detachment.

Authors:  Jiemei Shi; Kaicheng Wu; Huiming Wen; Jiaojiao Wei; Yuan Zong; Jian Yu; Haohao Zhu; Chunhui Jiang
Journal:  BMC Ophthalmol       Date:  2022-06-08       Impact factor: 2.086

3.  Vitrectomy Combined with Cataract Surgery for Retinal Detachment Using a Three-Dimensional Viewing System.

Authors:  Katarzyna Nowomiejska; Mario Damiano Toro; Vincenza Bonfiglio; Aleksandra Czarnek-Chudzik; Agnieszka Brzozowska; Kamil Torres; Robert Rejdak
Journal:  J Clin Med       Date:  2022-03-24       Impact factor: 4.241

4.  Comparison of Postoperative Stability of Intraocular Lenses after Phacovitrectomy for Rhegmatogenous Retinal Detachment.

Authors:  Ayaka Akiyama; Harumasa Yokota; Hiroshi Aso; Hirotsugu Hanazaki; Masanori Iwasaki; Satoru Yamagami; Taiji Nagaoka
Journal:  J Clin Med       Date:  2022-06-15       Impact factor: 4.964

5.  Rhegmatogenous retinal detachment repair-does age, sex, and lens status make a difference?

Authors:  Viola Radeck; Horst Helbig; David Maerker; Maria-Andreea Gamulescu; Philipp Prahs; Teresa Barth
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2022-05-02       Impact factor: 3.535

6.  Differences in Axial Length and IOL Power Based on Alternative A-Scan or Fellow-Eye Biometry in Macula-Off Rhegmatogenous Retinal Detachment Eyes.

Authors:  Rui Liu; Hongrong Li; Qingchen Li
Journal:  Ophthalmol Ther       Date:  2021-12-08

7.  The Role of Anterior Chamber Depth on Post-operative Refractive Error After Phacovitrectomy.

Authors:  Gabriel Katz; Fidaa El Zhalka; Ronel Veksler; Anfisa Ayalon; Elad Moisseiev
Journal:  Clin Ophthalmol       Date:  2021-05-20
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.